Unfractionated- versus low-molecular-wei
β
Gilles L. Fraser; Richard R. Riker
π
Article
π
2006
π
John Wiley and Sons
π
English
β 47 KB
I n the pharmacoeconomic evaluation of enoxaparin versus un- fractionated heparin (UFH) for the prevention of venous thrombosis in medical patients, Leykum et al. 1 concluded that lowmolecular-weight heparin (LMWH) offered greater cost utility. This important benefit was based on a single advantage